Lethality was reported for 392 (22.1% of the total) individuals with OI, of which 252 carried variants in COL1A1, representing 24.9% of all reported variants in that gene and 140 carried variants in COL1A2 (18.4%) (Fig. 3A). The gene discussed is COL1A2; the disease is osteogenesis imperfecta.